In our study, HbA1c, HOMA-IR, and plasma insulin per se were associated with an increased risk of liver cancer mortality among those without diabetes, a finding that is consistent with previous epidemiologic studies [38–40]. The gene discussed is INS; the disease is diabetes mellitus.